Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Patane

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|March 17, 2011
4-Aminothiazolyl analogues of GE2270 A: antibacterial lead findingMatthew J LaMarche, Jennifer A Leeds, JoAnne Dzink-Fox, et al.
Journal of Medicinal Chemistry|July 21, 2012
Antibiotic optimization and chemical structure stabilization of thiomuracin AMatthew J LaMarche, Jennifer A Leeds, Joanne Dzink-Fox, et al.
The Journal of Biological Chemistry|February 3, 2004
ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysisPaul Towler, Bart Staker, Sridhar G Prasad, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonistsR M DiPardo, M A Patane, R C Newton, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2017
Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosingBharat Lagu, Arthur F Kluge, Ross A Fredenburg, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2006
Identification and structure-activity relationships of a new series of Melanocortin-4 receptor antagonistsTricia J Vos, Suresh Balani, Christopher Blackburn, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2017
Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516Bharat Lagu, Arthur F Kluge, Matthew M Goddeeris, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Phenylacetamides as selective alpha-1A adrenergic receptor antagonistsM A Patane, R M DiPardo, R C Newton, et al.
ACS Medicinal Chemistry Letters|September 28, 2018
Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)Bharat Lagu, Arthur F Kluge, Effie Tozzo, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Correction to "Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)"Bharat Lagu, Arthur F Kluge, Effie Tozzo, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|March 17, 2011
4-Aminothiazolyl analogues of GE2270 A: antibacterial lead findingMatthew J LaMarche, Jennifer A Leeds, JoAnne Dzink-Fox, et al.
Journal of Medicinal Chemistry|July 21, 2012
Antibiotic optimization and chemical structure stabilization of thiomuracin AMatthew J LaMarche, Jennifer A Leeds, Joanne Dzink-Fox, et al.
The Journal of Biological Chemistry|February 3, 2004
ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysisPaul Towler, Bart Staker, Sridhar G Prasad, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonistsR M DiPardo, M A Patane, R C Newton, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2017
Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosingBharat Lagu, Arthur F Kluge, Ross A Fredenburg, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2006
Identification and structure-activity relationships of a new series of Melanocortin-4 receptor antagonistsTricia J Vos, Suresh Balani, Christopher Blackburn, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2017
Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516Bharat Lagu, Arthur F Kluge, Matthew M Goddeeris, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Phenylacetamides as selective alpha-1A adrenergic receptor antagonistsM A Patane, R M DiPardo, R C Newton, et al.
ACS Medicinal Chemistry Letters|September 28, 2018
Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)Bharat Lagu, Arthur F Kluge, Effie Tozzo, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Correction to "Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)"Bharat Lagu, Arthur F Kluge, Effie Tozzo, et al.
Pageof 3